Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 4, Issue 1, 2007, Pages 29-39

  Fan, Vincent S ^a,c   Ramsey, Scott D ^b,c   Make, Barry J ^d   Martinez, Fernando J ^e  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Chronic Obstructive Pulmonary Disease; Hospitalization; Logistic Models; Quality of life; Severity of Illness Index

Indexed keywords

AGED; AREA UNDER THE CURVE; ARTERIAL GAS; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISCRIMINANT ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EMERGENCY WARD; EMPHYSEMA; EXERCISE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIOLOGY DEPARTMENT; RISK; SPIROMETRY;

AGED; ANALYSIS OF VARIANCE; AREA UNDER CURVE; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; QUALITY OF LIFE; RESEARCH DESIGN; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 33847365003     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550601169430     Document Type: Article

References (43)

1. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003; 41:46s-53s.
2. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(5 Pt 1):1418-1422.
3. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004; 23(5):698-702.
4. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57(10):847-852.
5. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000; 117(2 Suppl):5S-9S.
6. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999; 130(5):397-403.
7. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003; 290(17):2301-2312.
8. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2003; 361(9356):449-456.
9. Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003; 21(1):74-81.
10. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003; 163(5):585-591.
11. Casas A, Troosters T, Garcia-Aymerich J, Roca J, Hernandez C, Alonso A, et al. Integrated care prevents hospitalizations for exacerbations in COPD patients. Eur Respir J 2006.
12. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997; 10(2):417-423.
13. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159(1):158-164.
14. Miravitlles M, Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, Segu JL. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration 2000; 67(5):495-501.
15. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58(2):100-105.
16. Oostenbrink JB, Rutten-van Molken MP. Resource use and risk factors in high-cost exacerbations of COPD. Respir Med 2004; 98(9):883-891.
17. Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al. Risk factors for rehospitalization in COPD: role of health status, anxiety and depression. Eur Respir J 2005; 26(3):414-419.
18. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(10):1005-1012.
19. Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005; 128(6):3810-3806.
20. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004; 159(9):882-890.
21. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348(21):2059-2073.
22. Rationale and design of the National Emphysema Treatment Trial (NETT). A prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg 1999; 118(3):518-528.
23. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001; 345(15):1075-1083.
24. Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 2003; 348(21):2092-2102.
25. Rawson NS, Malcolm E. Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med 1995; 14(24):2627-2643.
26. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155(4):1278-1282.
27. Sciurba F, Criner GJ, Lee SM, Mohsenifar Z, Shade D, Slivka W, et al. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 2003; 167(11):1522-1527.
28. Jones PW. A self-complete measure of health status for chronic airflow limitation: The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321-1327.
29. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest 1998; 113(3):619-624.
30. Ries A. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. J Chron Obstructive Pulm Dis 2005; 2:105-110.
31. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19(3):398-404.
32. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical co-morbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45(6):613-619.
33. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5):373-383.
34. Martinez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173:1326-1334.
35. Hosmer D, Lemeshow S. Applied Logistic Regression. New York: Wiley-Interscience, 1989.
36. Hosmer D, Lemeshow S. Applied Logistic Regression, 2nd ed. New York: John Wiley & Sons; 2000.
37. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44(3):837-845.
38. Harrell FE, Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15(4):361-387.
39. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Boca Raton, FL: Chapman & Hill; 1998.
40. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121(5):1434-1440.
41. Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Felez M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166(5):680-685.
42. Miravitlles M, Murio C, Guerrero T. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group. Eur Respir J 2001; 17(5):928-933.
43. Soler JJ, Sanchez L, Roman P, Martinez MA, Perpina M. Risk factors of emergency care and admissions in COPD patients with high consumption of health resources. Respir Med 2004; 98(4):318-329.